EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -0.1594
March 31, 2026 -0.2289
December 31, 2025 2.062
September 30, 2025 -0.6339
June 30, 2025 -1.556
March 31, 2025 -2.290
December 31, 2024 -7.974
September 30, 2024 -0.0411
June 30, 2024 -3.812
March 31, 2024 0.21
Date Value
December 31, 2023 -5.976
September 30, 2023 -0.0041
June 30, 2023 0.0496
March 31, 2023 0.0552
December 31, 2022 0.0389
September 30, 2022 0.0174
June 30, 2022 -0.0052
March 31, 2022 -0.0331
December 31, 2021 0.00
October 31, 2021 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics